TrialBlood advances2024

Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia.

Betty K Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.